A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Smokers aged 18 years or above and wanting to stop smoking
Smokers who have smoked an average of at least 10 cigarettes per day over the last 4 weeks
Smokers who have tried before to stop smoking at least once with varenicline, and who took varenicline for at least 2 weeks
The last attempt to stop smoking must be at least 3 months before entering the study
You may not be if
Individuals who have not tolerated varenicline well previously, or who have a current or prior medical or psychiatric history that would make entry into the trial inadvisable
Individuals who have previously participated in clinical trials of varenicline
Individuals who have been participating in another smoking cessation trial within the last 3 months, or other drug trial within the last 30 days
Clareo Health | A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider
